Form 4: Roivant Sciences Director Daniel Gold Reports Changes in Beneficial Ownership
SEC Form 4
Director Daniel Gold reports changes in beneficial ownership of Roivant Sciences shares due to an in-kind distribution and holdings through various entities.
Summary
- On March 7, 2024, Daniel Gold, a director of Roivant Sciences, reported changes in his beneficial ownership of the company's common shares.
- The changes are due to an in-kind distribution made by several entities, including QVT Roiv Hldgs Onshore Ltd., QVT Roiv Hldgs Offshore Ltd., Fourth Avenue Capital Partners LP, QVT P&E Roiv Hldgs Ltd., QVT Deferred Compensation Holdings Ltd, and QVT Financial Investment Cayman Ltd.
- Gold also holds shares directly and indirectly through trusts and estate planning vehicles.
- The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein.
- The report also includes shares received as part of the distribution described above, which is exempted under both Rule 16a-9 and Rule 16a-13 as a change in form of beneficial ownership and (i) an annual award of restricted stock units with respect to Common Shares ('RSUs') granted pursuant to the Company's 2021 Equity Incentive Plan and the Company's Non-Employee Director Compensation Policy (the 'Equity Plan'), which vested on September 15, 2023 and (ii) an annual award of restricted stock units with respect to RSU granted pursuant to the Equity Plan, which is scheduled to vest 100% on September 12, 2024, subject generally to the reporting person's continuous service through such date.
Sentiment
Score: 5
Explanation: This is a routine filing related to changes in beneficial ownership, so the sentiment is neutral.
Future Outlook
The report mentions RSUs that are scheduled to vest on September 12, 2024, subject to continued service.
Industry Context
Form 4 filings are a standard part of regulatory compliance for company insiders, providing transparency into their transactions in the company's stock.
Key Dates
| Date | Description |
|---|---|
| 03/07/2024 | Date of the reported transaction and filing of the Form 4. |
| 09/15/2023 | Date of vesting of an annual award of restricted stock units with respect to Common Shares ('RSUs') granted pursuant to the Company's 2021 Equity Incentive Plan and the Company's Non-Employee Director Compensation Policy (the 'Equity Plan'). |
| 09/12/2024 | Date of scheduled vesting of an annual award of restricted stock units with respect to RSU granted pursuant to the Equity Plan, which is scheduled to vest 100% on September 12, 2024, subject generally to the reporting person's continuous service through such date. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.